1. Melanoma overview. a dangerous skin cancer. Accessed: January 23, 2015: http://www.skincancer.org/skin-cancer-information/melanoma.
2. Review of indications of FDA-approved immune checkpoint inhibitors per NCCN guidelines with the level of evidence;Vaddepally RK;Cancers (Basel),2020
3. Opdivo (Nivolumab): second PD-1 inhibitor receives FDA approval for unresectable or metastatic melanoma;Raedler LA;Am Health Drug Benefits,2015
4. CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients;Ott PA;Clin Cancer Res,2013
5. Recent advances in therapeutic strategies for unresectable or metastatic melanoma and real-world data in Japan;Uhara H;Int J Clin Oncol,2019